Paracelsian Inc (PRLN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Richard Mazzarella who wrote (289)	8/13/1996 4:40:00 PM
From: Rick Costantino	of 4342

I'm back from vacation and glad to see that Paracelsian has been pretty steady. I found the following (old news) in Clinical Investigator News, August 1996... ***************************************************************** Infectious Diseases AIDS breakthroughs The big news at the XI International AIDS Conference in Vancouver last month was the huge decrease in HIV load seen in patients treated with various combinations of approved anti-viral drugs. The biotech industry was also well represented at the conference and made some fairly significant announcements of its own. A National INstitutes of Health (Bethesada, MD) researcher has shown that c-mos kinase iss necessary for HIV replication in T cells. This proved significant for companies like Paracelsian Inc. (Ithaca, NY) and other that are targetting this enzyme in HIV therapies. ****************************************************************** Like I said, old news, but hmm....who are those "others" that are apparently competing with Paracelsian on c-mos kinase inhibitors? Any ideas? I am very interested in much-awaited conference call...when will it be? Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next